MILAN — Treatment of rheumatoid arthritis (RA) with tumor necrosis factor inhibitors (TNFi) does not appear to demonstrate a consistent and significant risk for demyelinating disease, according to a ...
Hemoglobin is a protective factor against C-reactive protein in rheumatoid arthritis, potentially slowing disease progression. A significant correlation between hemoglobin and CRP was found, even ...
Rheumatoid arthritis (RA) is a chronic autoimmune disorder whose hallmark symptom is inflammation in the joints resulting in swelling, pain, and stiffness. But RA, particularly if left untreated or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results